This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hoffmann-La Roche Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Helene Maria Gylling: Innovator in Oligonucleotide Technology
Introduction
Helene Maria Gylling is a prominent inventor based in Hvidovre, Denmark. She has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotides. Her work focuses on enhancing the modulation of gene expression, which has important implications for medical research and therapeutic applications.
Latest Patents
Gylling holds a patent titled "Enhanced Oligonucleotides for Modulating FUBP1 Expression." This innovative patent represents her commitment to advancing genetic research and offers potential solutions for various health-related challenges. She has 1 patent to her name, showcasing her expertise and dedication to her field.
Career Highlights
Throughout her career, Gylling has been associated with Hoffmann-La Roche Inc., a leading global healthcare company. Her role at the company has allowed her to collaborate with other talented professionals and contribute to groundbreaking research in biotechnology.
Collaborations
Gylling has worked alongside notable colleagues, including Sabine Sewing and Natascha Hruschka. These collaborations have enriched her research and expanded the impact of her innovations in the scientific community.
Conclusion
Helene Maria Gylling is a remarkable inventor whose work in oligonucleotide technology is paving the way for advancements in gene modulation. Her contributions are vital to the ongoing evolution of biotechnology and its applications in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile